India’s primary market is set for a busy Monday, December 15, with two IPO listings scheduled, one large mainboard issue entering its second day of bidding, and allotments expected for two healthcare offerings that drew strong investor interest last week.
Shares of Wakefit Innovations Ltd are slated to list on the NSE and BSE today. The Rs 1,289-crore IPO was subscribed 2.52 times overall, with retail investors leading demand at 3.17 times, followed by QIBs at 3.04 times. Wakefit Innovations public issue attracted relatively modest grey market interest, with the GMP hovering around 2 percent ahead of listing. Wakefit had raised Rs 580 crore from anchor investors prior to opening the issue.
Corona Remedies also makes its market debut today after one of the strongest subscription responses seen this year. The Rs 655-crore offer-for-sale was subscribed over 137 times, led by extremely strong demand from QIBs and NIIs. As Corona Remedies public issue was entirely an OFS, listing performance will be closely watched as a reflection of investor confidence in the company’s fundamentals rather than balance-sheet expansion, said an analyst.
The ICICI Prudential AMC IPO, one of the largest issues in the current pipeline, enters its second day of bidding today. The Rs 10,603-crore offer was subscribed 72 percent on Day 1, supported by late but decisive participation from Qualified Institutional Buyers, who subscribed their portion nearly two times by the end of the session.
Retail, shareholder and non-institutional investor segments also continued to build steadily, though overall subscription remained driven by institutional interest. The IPO, which is a 100 percent offer-for-sale, closes on December 16, with listing scheduled for December 19. The grey market premium has edged up to around 7–9 percent, from about 5-6 percent a day earlier.
Attention today also turns to IPO allotments for two healthcare companies.
The Park Medi World IPO allotment is scheduled to be finalised today. The issue was subscribed 8.52 times overall, with strong interest from NIIs and healthy participation from QIBs. Refunds to unsuccessful bidders and credit of shares to demat accounts are expected on December 16, with listing slated for December 17.
Similarly, Nephrocare Health Services is expected to finalise its IPO allotment today after the issue was subscribed over 14 times. Institutional investors dominated the book, while retail participation remained moderate. The company is scheduled to list on December 17.
With two listings, a marquee AMC IPO gathering momentum, and multiple allotments due, today’s primary market action offers investors cues on risk appetite and listing sentiment. The performance of Wakefit and Corona Remedies on debut will be closely watched.
Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.